We are proud to announce that we have been selected as one of the 120 most promising deep tech companies in the European Union to join the prestigious European Innovation Council (EIC) Scaling Club. We are excited to embark on this new chapter as one of 12 companies in the New Biotech sector.

The EIC Scaling Club is dedicated to accelerating the growth of its members, with the ambitious goal of transforming 20% of them into unicorns. This opportunity strengthens our commitment to revolutionize cancer diagnostics and treatment. Together with our mentors and fellow innovators, we aim to achieve a future where cancer is detected early and treated successfully.

We look forward to the collaboration and future success!